DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans

By Ugen K.E.   Nyland S.B.   Boyer J.D.   Vidal C.   Lera L.   Rasheid S.   Chattergoon M.   Bagarazzi M.L.   Ciccarelli R.   Higgins T.   Baines Y.   Ginsberg R.   Macgregor R.R.   Weiner D.B.  

Vaccine, Vol. 16, Iss. 19, 1998-11 ,pp. : 1818-1821

Elsevier

Access to resources Recommend Favorite

Immunogenicity of an HIV-1 gag DNA vaccine carried by attenuated Shigella

By Xu F.   Hong M.   Ulmer J.B.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 644-648

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-1 infected former drug users

By Amendola A.   Tanzi E.   Zappa A.   Colzani D.   Boschini A.   Musher D.M.   Zanetti A.R.  

Vaccine, Vol. 20, Iss. 31, 2002-11 ,pp. : 3720-3724

Elsevier

Access to resources Recommend Favorite

A Phase I safety and immunogenicity trial of UBI(R) microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects

By Lambert J.S.   Keefer M.   Mulligan M.J.   Schwartz D.   Mestecky J.   Weinhold K.   Smith C.   Hsieh R.   Moldoveanu Z.   Fast P.   Forrest B.   Koff W.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3033-3042

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of REMUNE TM in HIV-infected Thai subjects

By Limsuwan A.   Churdboonchart V.   Moss R.B.   Sirawaraporn W.   Sutthent R.   Smutharaks B.   Glidden D.   Trauger R.   Theofan G.   Carlo D.  

Vaccine, Vol. 16, Iss. 2, 1998-01 ,pp. : 142-149

Elsevier

Access to resources Recommend Favorite